Finance

Lists
Why is NXTC up ၂.၆၂%?
Dive Deeper
NXTC:NASDAQ
NextCure Inc
၅.၀၉ US$
+၂.၆၂%
(+၀.၁၃) 1D
အောက် ၂, GMT-၄ ၁၆:၀၀:၀၀  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for NXTC...
Open
၅.၁၇ US$
High
၅.၄၀ US$
Low
၄.၈၅ US$
Mkt. cap
၂.၃၃ ကုဋေ
Avg. vol.
၁.၀၁ သိန်း
Volume
၀.၀၀
52-wk high
၁၅.၇၄ US$
52-wk low
၁.၅၅ US$
EPS
-၁၀.၂၇ US$
Beta
၁.၃၃
Shares outstanding
၄.၅၈ သန်း
No. of employees
၄၀
Open
၅.၁၇ US$
High
၅.၄၀ US$
Low
၄.၈၅ US$
Mkt. cap
၂.၃၃ ကုဋေ
Avg. vol.
၁.၀၁ သိန်း
Volume
၀.၀၀
52-wk high
၁၅.၇၄ US$
52-wk low
၁.၅၅ US$
EPS
-၁၀.၂၇ US$
Beta
၁.၃၃
Shares outstanding
၄.၅၈ သန်း
No. of employees
၄၀
News stories
From web sources and news partners
BigGo Finance
BigGo Finance
·
ပြီးခဲ့သည့် ၄၉ မိနစ်
OKX Partners with NYSE Parent to Pursue Tokenized Stock Platform in the U.S.
MarketBeat
MarketBeat
·
ပြီးခဲ့သည့် ၃၂ မိနစ်
Consumer Portfolio Services (NASDAQ:CPSS) Cut to "Hold" at Wall Street Zen
About NextCure Inc
CEO-
Employees၄၀
Founded၂၀၁၅
Headquarters-
Sector-
Analyst ratings
Based on 1 analyst giving stock ratings to NXTC in the past 3 months
Buy
Buy
1
Hold
0
Sell
0
12-month forecast
Based on 1 Wall Street analyst offering 12-month price targets for NXTC in the last 3 months
Highest
Current ၅.၀၉ US$
၂၀.၀၀ US$ (+၂၉၂.၉၃%)
Average
၂၀.၀၀ US$ (+၂၉၂.၉၃%)
Lowest
၂၀.၀၀ US$ (+၂၉၂.၉၃%)
Analyst
Recommendation
Action
Price target
Projected
Date
Emily Bodnar
H.C. Wainwright
Buy
Reiterated
၂၀.၀၀ US$
+၂၉၂.၉%
08/13/2026
Edward Tenthoff
Piper Sandler
Buy
Maintained
၁၅.၀၀ US$
+၁၉၄.၇%
06/10/2026
Christopher Liu
Lucid Capital
Buy
Maintained
၂၅.၀၀ US$
+၃၉၁.၂%
06/02/2026
Kevin DeGeeter
Ladenburg Thalmann & Co.
Buy
Upgraded
၁၈.၀၀ US$
+၂၅၃.၆%
11/07/2025
Last report
၂၀၂၆ ဩ ၆
Fiscal period
Q2 2026
EPS / Est. (USD)
-၁.၈၅ US$ / -၁.၉၂ US$
+၃.၈၅%beat
Revenue / Est. (USD)
- / ၀.၀၀
Fiscal Q2 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
၂၀၂၅ စက်
၂၀၂၅ ဒီ
၂၀၂၆ မတ်
၂၀၂၆ ဇွန်
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
၆.၁၄ သန်း
၆.၈၀ သန်း
၆.၈၃ သန်း
၇.၄၂ သန်း
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
၂.၈၁ သန်း
၂.၉၆ သန်း
၃.၂၇ သန်း
၂.၅၉ သန်း
Operating expense
၈.၉၄ သန်း
၉.၇၆ သန်း
၁.၀၁ ကုဋေ
၁.၀၀ ကုဋေ
Total operating expenses
၈.၉၄ သန်း
၉.၇၆ သန်း
၁.၀၁ ကုဋေ
၁.၀၀ ကုဋေ
Operating income
-၈.၉၄ သန်း
-၉.၇၆ သန်း
-၁.၀၁ ကုဋေ
-၁.၀၀ ကုဋေ
Other non operating income
-
-
-
-
EBT including unusual items
-၈.၆၂ သန်း
-၉.၄၄ သန်း
-၉.၈၀ သန်း
-၁.၄၉ ကုဋေ
EBT excluding unusual items
-၈.၆၂ သန်း
-၉.၄၄ သန်း
-၉.၈၀ သန်း
-၉.၈၂ သန်း
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-၈.၆၂ သန်း
-၉.၄၄ သန်း
-၉.၈၀ သန်း
-၁.၄၉ ကုဋေ
Net profit margin
-
-
-
-
Earnings per share
-၃.၂၂
-၀.၈၁
-၁.၈၇
-၁.၈၅
Interest and investment income
၃.၂၁ သိန်း
၃.၂၁ သိန်း
၃.၀၉ သိန်း
၂.၀၂ သိန်း
Interest expense
-
-
-
-
Net interest expenses
၃.၂၁ သိန်း
၃.၂၁ သိန်း
၃.၀၉ သိန်း
၂.၀၂ သိန်း
Depreciation and amortization charges
-
-
-
-
EBITDA
-၈.၄၁ သန်း
-၉.၃၉ သန်း
-၉.၈၂ သန်း
-၉.၇၄ သန်း
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
Google အက်ပ်များ